Literature DB >> 14528515

Maternal age and family history are risk factors for ankylosing spondylitis.

F Javier Jiménez-Balderas1, Abraham Zonana-Nacach, M Lourdes Sánchez, Juan O Talavera, Leonor Barile-Fabris, Martha E Pérez-Rodríguez, Jorge Arellano, Antonio Fraga.   

Abstract

OBJECTIVE: To investigate prevalence and gender distribution in parents of children with ankylosing spondylitis (AS).
METHODS: Family history of AS (parents, uncles, and aunts), maternal age at delivery, and consecutive pregnancy number were assessed in the relatives of 40 Mexican Mestizo patients with definite AS (New York Criteria).
RESULTS: We evaluated the family history of AS in 34 families of 40 AS patients; 12 with none, 4 with a paternal history (4 healthy fathers with a brother with AS) (odds ratio, OR, 1.37, p = 0.75), 15 with a maternal history of AS, (15 healthy mothers with a brother with AS) (OR 1.4, p = 0.55), and 3 with both lines (OR 0.84, p = 0.92). In these families AS was more frequent in males (29%) than in females (10%), OR 3.40 (95% confidence interval, CI: 1.43-8.29, p = 0.003). Juvenile onset was more common in the offspring of mothers with family history (72%) (OR 13.0, 95% CI: 1.68-147.48, p = 0.009). The number of first-born children with AS (18%) was similar to the later-born children (23%) (OR 1.37, 95% CI: 0.38-5.31, p = 0.78). The frequency of AS increased when the maternal age at delivery was < or = 30 years (OR 0.20, 95% CI: 0.04-0.75, p = 0.01).
CONCLUSION: In Mexican Mestizo patients, there is no correlation between the risk for AS and the gender of the affected parent. However we found an association between juvenile onset and maternal family history with an increased incidence in patients with younger mothers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528515

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  1 in total

1.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.